Tissue Regenix Group (TRX) Insider Trading & Ownership GBX 61 -0.50 (-0.81%) (As of 11/15/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsInsider Trades Tissue Regenix Group (LON:TRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage47.34%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)£50,321.92Number OfInsiders Selling(Last 3 Years)0 Get TRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Tissue Regenix Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TRX Insider Buying and Selling by Quarter Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. Tissue Regenix Group Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/15/2023Brian PhillipsInsiderBuy6,773GBX 54£3,657.424/4/2023Daniel LeeInsiderBuy500,000GBX 1£5,0004/19/2022Trevor PhillipsInsiderBuy2,758,000GBX 1£27,58012/22/2021Daniel LeeInsiderBuy1,408,450GBX 1£14,084.50 (Data available from 1/1/2013 forward) TRX Insider Trading Activity - Frequently Asked Questions Who is on Tissue Regenix Group's Insider Roster? The list of insiders at Tissue Regenix Group includes Brian Phillips, Daniel Lee, and Trevor Phillips. Learn more on insiders at TRX. What percentage of Tissue Regenix Group stock is owned by insiders? 47.34% of Tissue Regenix Group stock is owned by insiders. Learn more on TRX's insider holdings. Which Tissue Regenix Group insiders have been buying company stock? The following insiders have purchased TRX shares in the last 24 months: Brian Phillips (£3,657.42), and Daniel Lee (£5,000). How much insider buying is happening at Tissue Regenix Group? Insiders have purchased a total of 506,773 TRX shares in the last 24 months for a total of £8,657.42 bought. Tissue Regenix Group Key ExecutivesMr. Daniel Ray Lee (Age 63)CEO & Director Compensation: $488.78kMr. David Claiborne Cocke (Age 59)CFO & Executive Director Compensation: $288.86kMs. Christine RowleyTechnical & Operations Director - UKTina TrimbleSenior Vice President, Donor Services - U.S.Ms. Kirsten Mary LundEMEA Business Director & Company Secretary More Insider Trading Tools from MarketBeat Related Companies National Grid Insider Ownership Severfield Insider Ownership 4basebio Insider Ownership e-therapeutics Insider Ownership Poolbeg Pharma Insider Ownership Sareum Insider Ownership Oncimmune Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (LON:TRX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tissue Regenix Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Tissue Regenix Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.